Patents by Inventor Ronald Wiehle

Ronald Wiehle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions with -clomiphene
    Patent number: 7737185
    Abstract: The present invention relates to the use of compositions comprising trans-clomiphene for treating wasting, especially a loss of muscle mass. The invention is also directed to methods for treating wasting in a patient with chronic obstructive pulmonary disorder. The present invention is also directed to methods for treating hypogonadism in males with chronic obstructive pulmonary disorder.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: June 15, 2010
    Assignee: Repros Therapeutics Inc.
    Inventors: Joseph S. Podolski, Ronald Wiehle
  • METHODS AND MATERIALS FOR CONTROLLING RODENT POPULATIONS
    Publication number: 20080287549
    Abstract: The present invention relates to the use of compositions comprising clomiphene isomers for controlling rodent populations. The clomiphene isomers lower testosterone and/or suppress appetite in the rodent population.
    Type: Application
    Filed: May 17, 2007
    Publication date: November 20, 2008
    Inventors: Joseph S. Podolski, Ronald Wiehle, Kuang Hsu
  • Methods and compositions with trans-clomiphene
    Patent number: 7368480
    Abstract: The present invention relates to the use of compositions comprising trans-clomiphene for treating men with hypogonadism. The invention is also directed to methods for treating males with hypogonadism. The present invention is also directed to methods of decreasing cholesterol levels.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: May 6, 2008
    Assignee: Repros Therapeutics Inc.
    Inventors: Joseph S. Podolski, Ronald Wiehle
  • METHODS AND COMPOSITIONS WITH TRANS-CLOMIPHENE
    Publication number: 20070249726
    Abstract: The present invention relates to the use of compositions comprising trans-clomiphene for treating wasting, especially a loss of muscle mass. The invention is also directed to methods for treating wasting in a patient with chronic obstructive pulmonary disorder. The present invention is also directed to methods for treating hypogonadism in males with chronic obstructive pulmonary disorder.
    Type: Application
    Filed: May 17, 2007
    Publication date: October 25, 2007
    Inventors: Joseph Podolski, Ronald Wiehle
  • Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
    Patent number: 7173064
    Abstract: The present invention discloses compositions and methods useful for treating wasting, especially a loss of muscle mass. The present invention also discloses compositions and methods useful for treating lipodystrophy. The compositions and methods of the present invention are particularly beneficial to HIV-infected individuals.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: February 6, 2007
    Assignee: Repros Therapeutics Inc.
    Inventors: Joseph S. Podolski, Ronald Wiehle
  • Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
    Publication number: 20040171697
    Abstract: The present invention discloses compositions and methods useful for treating wasting, especially a loss of muscle mass. The present invention also discloses compositions and methods useful for treating lipodystrophy. The compositions and methods of the present invention are particularly beneficial to HIV-infected individuals.
    Type: Application
    Filed: November 12, 2003
    Publication date: September 2, 2004
    Applicant: ZONAGEN, INC.
    Inventors: Joseph S. Podolski, Ronald Wiehle
  • Methods and compositions with trans-clomiphene
    Publication number: 20040097597
    Abstract: The present invention relates to the use of compositions comprising trans-clomiphene for treating men with hypogonadism. The invention is also directed to methods for treating males with hypogonadism. The present invention is also directed to methods of decreasing cholesterol levels.
    Type: Application
    Filed: April 30, 2003
    Publication date: May 20, 2004
    Applicant: Zonagen, Inc.
    Inventors: Joseph S. Podolski, Ronald Wiehle